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        Human cancer develops via a multistep process 
that can be divided both operationally and mech-
anistically into three phases: initiation, promo-
tion, and progression (  1, 2  ). Several lines of 
evidence, including general or tissue-specifi  c gene 
inactivation in mice and population-based studies, 
support the assumption that infl  ammation plays 
an important role during carcino  genesis (  3, 4  ). 
Therefore, it is widely accepted that many 
neoplastic diseases are driven, at least in part, by 
chronic and often subclinical infl  ammation (  4, 5  ). 
Chemically induced skin carcinogenesis is one 
of the best-established in vivo models to study 
the multistage nature of tumor development, and 
it represents a classical infl  ammation-associated 
tumor model, as its promotion phase solely 
depends on repeated topical treatments with TPA, 
a potent inducer of dermal infl  ammation (  2, 6  ). 
Moreover, antiinfl   ammatory treatment during 
the promotion phase with dexamethasone or 
nonsteroidal antiinfl  ammatory drugs interferes 
with TPA-induced tumor formation (  4  ). Despite 
this experimental evidence, the exact molecular 
mechanisms linking sustained,   “  smoldering  ”   
infl  ammation and carcinogenesis in this chemi-
cally induced tumor model still remain largely 
elusive. Recent data have highlighted the impo r-
tance of proinfl  ammatory signaling pathways in 
tumor promotion, because mice defi  cient for the 
cytokine   Tnf-          or its receptors (  Tnfr1   or   2  ) are 
resistant to DMBA/TPA-induced skin carcino-
genesis (  4, 7  ). 
  In this report, we describe a novel mechanis-
tic role for the receptor for advanced glycation 
end-products (RAGE) in linking infl  ammation 
and cancer using a defi  ned genetic   Rage   knock-
out mouse model. RAGE is a member of the 
immunoglobulin superfamily that has multiple 
extracellular ligands, is implicated in the patho-
genesis of various infl  ammatory disorders, and 
plays a potent role in innate immunity (  8, 9  ). 
  Rage  -defi  cient mice are protected from the lethal 
eff  ects of septic shock caused by cecal ligation 
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CD11b  +   Gr-1  +   subset that were not found in   Rage      /        tu-
mors (Fig. S2 D). These cells are known to induce T lym-
phocyte dysfunction and, therefore, actively inhibit antitumor 
adaptive immunity (  5  ). 
  As a potent activator of infl  ammation, TPA triggers strong 
up-regulation of proinfl   ammatory mediators and cytokines 
that subsequently results in dermal infi  ltration by immune cells 
and in epidermal hyperplasia (  2  ). To test whether   Rage   defi  -
ciency aff  ects the kinetics and dynamics of the transient in-
fl  ammatory response induced by TPA, we studied the dermal 
infi  ltration in   wt   and   Rage      /        back skin over time. 6 h after a 
single TPA application in   wt   skin, dermal infi  ltration by neu-
trophils, macrophages, and mast cells was observed by histo-
logical examination, and by specifi  c IF analysis with a further 
increase after 12 h (  Fig. 2, B and C  ). Strong dermal infi  ltration 
was maintained for 24 h but decreased 48 h after TPA applica-
tion. Although an initial dermal infi  ltration was also seen in 
  Rage      /        skin sections after 6 and 12 h, signifi  cantly fewer in-
nate immune cells were detected compared with   wt   controls at 
24 and 48 h (mast cells, P   <   0.001; macrophages, P   <   0.001; 
neutrophils, P   <   0.001;   Fig. 2, B and C  ). Similar data were 
also obtained with DMBA-pretreated animals (Fig. S3, available 
at http://www.jem.org/cgi/content/full/jem.20070679/DC1), 
excluding a major impact of DMBA initiation on the pro-
infl  ammatory response of TPA on mouse back skin. 
  Our observation that ablation of RAGE signaling causes 
impaired tumor growth is consistent with previous data by 
Taguchi et al., who observed suppression of TPA-induced 
tumor formation in a   v-Ha-ras    –  transgenic mouse tumor model 
using sRAGE, a soluble antagonist of RAGE (  15  ). However, 
in this study both the eff  ect of sRAGE treatment on the in-
fl  ammatory response and the functional mechanism for RAGE 
signaling during tumor promotion remained undefi  ned. More-
over, it is important to note that sRAGE has an impact on multi-
ple immune responses even in the absence of functional RAGE, 
leading to the assumption that the benefi  cial eff  ects of sRAGE 
in mouse disease models are not solely caused by preventing 
ligand engagement of RAGE (  10  ). 
  To identify functional candidate genes that refl  ect the dif-
ferences in the transient TPA response between  wt   and  Rage      /        
skin, we analyzed the expression kinetics of proinfl  ammatory 
genes that are known to be important players in skin carcino-
genesis (  7, 16  ). Real-time quantitative PCR (RQ-PCR) with 
complementary DNA (cDNA) samples of skin derived from 
distinct time points after a single TPA treatment revealed an 
impaired induction of   Prostaglandin-endoperoxide synthase 2   (  Ptgs2  ) 
in   Rage      /        skin samples compared with   wt   controls (  Fig. 3 A  ).   
  Ptgs2   encodes for the proinfl  ammatory mediator cyclooxy-
genase-2 (COX-2), and indirect IF analysis on DMBA/TPA-
induced tumor sections with a COX-2  –  specifi  c antibody 
revealed only scarce positive staining in   Rage      /        samples, 
whereas strong staining was detected in both tumor and stro-
mal cells of   wt   controls (Fig. S4, available at http://www.jem
.org/cgi/content/full/jem.20070679/DC1). These data are 
in accordance with recent fi  ndings demonstrating a RAGE-
dependent   Ptgs2   up-regulation in distinct cell types (  17, 18  ), and 
and puncture (  10  ), providing experimental evidence for its 
contribution, at least in part, to the development of distinct 
infl  ammatory diseases (  8, 9  ). In the context of cancer, elevated 
expression levels of RAGE and its ligands have been detected 
in a growing number of tumor types (  8, 11  ). We demonstrate 
that RAGE signaling drives tumor development by sustaining 
infl  ammation during the promotion phase of chemically in-
duced carcinogenesis, and defi  ne key proinfl  ammatory media-
tors and cytokines as novel targets of RAGE signaling. Given 
the close association between chronic infl  ammation and epi-
thelial cancer, we propose that RAGE activation by its ligands 
establishes a sustained tissue activation, which over time pro-
motes tumor development. 
    RESULTS AND DISCUSSION   
  To elucidate the role of RAGE in multistage skin carcinogen-
esis, we subjected wild-type (  wt  ) and   Rage  -defi  cient (  Rage      /       ) 
female mice to a single topical application with the carcinogen 
DMBA, followed by promotion with the phorbol ester TPA 
for 30 wk. After 8 wk of promotion, tumors were exclusively 
found on   wt   back skin, and by 13 wk all   wt   mice had devel-
oped tumors (  Fig. 1 A  , left).   In contrast,   Rage      /        mice devel-
oped the fi  rst tumors after 14 wk of promotion (P   <   0.0001 
for the time to fi  rst tumor appearance), and the maximal tu-
mor incidence was only 58%. Moreover, we detected a highly 
signifi  cant diff  erence (P   <   0.0001) in tumor multiplicity, with 
5.1 tumors per mouse in   wt   controls but only 1.1 tumors per 
mouse in   Rage      /        animals (  Fig. 1 A  , right). Overall,   Rage      /        
tumors were smaller in size, appeared less progressed, and 
were highly diff  erentiated and hyperkeratotic (  Fig. 1 B  ; and 
Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20070679/DC1). Detailed analysis of tissue sections de-
rived from   Rage      /        tumors in comparison to   wt   tumors by 
immunohistochemistry (IHC) revealed a signifi  cantly lower 
level of Ki67- and BrdU-positive tumor cells (P   <   0.0001; 
  Fig. 1 C   and Fig. S2 A), as well as fewer cells showing Jun 
protein phosphorylation (Fig. S2 B), a protooncogenic tran-
scription factor of the activator protein 1 family crucial for ke-
ratinocyte proliferation and neoplastic transformation (  12, 13  ). 
We also found increased apoptosis of epidermal tumor cells in 
  Rage      /        tumors compared with   wt   controls using a Tdt-medi-
ated dUTP-biotin nick-end labeling (TUNEL) assay (  Fig. 1 D  ) 
in concert with a signifi  cant decrease (P   <   0.0001) in nuclear 
staining for phosphorylated p65/RelA, a member of the NF-     B 
transcription factor implicated in antiapoptotic signaling (  14  ), 
using indirect immunofl  uorescent (IF) analysis (  Fig. 1, D and E  ). 
Thus, the reduction in tumor size of   Rage      /        mice may be at 
least partially explained by the low proliferation rate and the 
increase in apoptosis. 
  Importantly, histological analysis of   Rage  -defi  cient tumors 
revealed signifi  cantly impaired stromal infi  ltration by mast 
cells (P   <   0.0001), macrophages (P   <   0.0001), and neutro-
phils (P   <   0.003) compared with   wt   controls (  Fig. 2 A   and 
Fig. S2 C), suggesting RAGE-dependent activation of an 
infl   ammatory tumor microenvironment.   Extended analysis 
further indicated that   wt   tumors harbor myeloid cells of the JEM VOL. 205, February 18, 2008  277
BRIEF DEFINITIVE REPORT
  “  autopromoted  ”   state and to drive tumor development in 
DMBA-initiated skin without TPA treatment (  19  ). 
  In TPA-treated   wt   skin, we also measured dramatic changes 
for the macrophage infl  ammatory protein (MIP) family mem-
bers   Mip-1      ,   Mip-1      , and   Mip-2   using RQ-PCR, whereas 
regarding the important role of this enzyme as a proinfl  amma-
tory mediator representing a major target for cancer chemo-
prevention by nonsteroidal antiinfl  ammatory drugs (  16, 19  ). 
Indeed, ectopic COX-2 overexpression in the skin of trans-
genic mice is suffi   cient to transform the epidermis into an 
    Figure 1.           Rage      /        mice are protected against DMBA/TPA-induced tumor development.   (A)   wt   and   Rage    /      mice were subjected to the DMBA/TPA 
skin carcinogenesis protocol and were assessed and statistically analyzed as described in Materials and methods. The graphs display the number of 
tumor-bearing mice (left, incidence) and the mean number of tumors per mouse (right, multiplicity) at the indicated time points after DMBA treatment. 
(B) Representative macroscopic pictures (top) and bright-fi  eld microscopic views of hematoxylin-eosin  –  stained sections (bottom) of   wt   and   Rage    /      tumors. 
Bars: (top) 1 mm; (bottom) 200   μ  m. (C) The percent total of Ki67-labeled tumor cells of three tumors from each genotype was calculated as described 
in Materials and methods. (D) Representative pictures of   wt   and   Rage    /      tumor sections that were analyzed by TUNEL assay (top, red signal) and by indi-
rect IF staining of phospho-p65 protein (bottom, red signal), as described in Materials and methods. Nuclear staining was done with H33342 (blue signal). 
Inset shows a higher magnifi  cation of phospho-p65 stained nuclei. Bar, 100   μ  m. (E) The percent total of phospho-p65  –  labeled tumor cells within three 
tumors from each genotype was calculated as described in Materials and methods. Error bars represent the SEM.     278 RAGE SIGNALING PROMOTES INFLAMMATION AND CANCER | Gebhardt et al.
by an excess concentration of residual chemokines, a sustained 
infl  ammatory response to TPA (  20  ), and an increased suscepti-
bility to tumor development in the DMBA/TPA model (  21  ). 
  The targets of RAGE signaling identifi  ed in the present 
study are well-known target genes of NF-     B, an essential 
player in the neoplastic transformation of keratinocytes and 
in linking infl  ammation to cancer development and progres-
sion (  14, 22  ). In this context, it is noteworthy that RAGE is 
a potent inducer of NF-     B signaling and has the unique ability 
to sustain NF-     B activation through de novo synthesis of   RelA   
messenger RNA, providing a constant pool of transcriptional 
active NF-     B neutralizing endogenous, limiting autoregula-
tory mechanisms (  23  ). 
mild diff  erences in   Tnf-       induction and only minor alterations 
for   Tgf-       transcript levels were observed (  Fig. 3 A  ). In contrast, 
only marginal induction was seen in   Rage      /        skin, demonstrat-
ing that these well-known eff  ectors of chemotaxis and infl  am-
mation are novel targets of RAGE signaling. IHC analysis 
confi  rmed reduced amounts of infi  ltrating immune cells and/or 
epithelial cells expressing MIP proteins in back skin upon a single 
TPA application or within   Rage      /        tumors (  Fig. 3 B  ; and Figs. 
S4 and S5, available at http://www.jem.org/cgi/content/
full/jem.20070679/DC1). MIP-1     , MIP-1     , and MIP-2 are 
chemokines responsible for the recruitment of polymorpho-
nuclear cells at sites of infl  ammation (  20  ), and mice defi  cient 
for their scavenging decoy receptor D6 were characterized 
    Figure 2.         Impaired infl  ammatory response in   Rage      /        mice.   (A) Innate immune cells within the stroma of at least six   wt   and   Rage    /      tumors  were 
counted based on indirect IF stainings for neutrophils (antineutrophils, black bars) and macrophages (anti-CD68, gray bars), or on toluidine blue staining for 
mast cells (white bars), and are given as cells per square millimeter. Values represent means   ±   SEM from three mice from each genotype. (B) Representative 
pictures of hematoxylin-eosin  –  stained   wt   and   Rage    /      skin specimens that were collected at the indicated time points after a single topical treatment of 
acetone (co) or 10 nmol TPA in acetone. Dashed lines indicate the border between the epidermis and dermis. Bar, 20   μ  m. (C) Innate immune cells within the 
dermis of at least three   wt   and   Rage    /      mice treated as described in B were counted based on specifi  c stainings and analyzed as described in A.    JEM VOL. 205, February 18, 2008  279
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for   S100a8   transcript levels (Fig. S3 C). IHC analysis confi  rmed 
diff  erential expression on protein levels (  Fig. 3 B   and Fig. S5), 
implying that both act not only as RAGE ligands but also rep-
resent target genes of RAGE signaling. This assumption is in 
accordance with recent fi  ndings showing that RAGE main-
tains cellular activation by induction of its own extracellular 
ligands (  25, 26, 8  ). 
  To further strengthen the concept of RAGE-dependent 
perpetuation of infl  ammation, we analyzed the consequence 
of RAGE defi  ciency on repeated TPA treatment and chal-
lenged the back skin three times every 48 h, representing the 
promotion stage of the DMBA/TPA protocol.   wt   animals de-
veloped a strong dermal infi  ltration and a marked epidermal 
  Previously, global gene expression profi  ling on samples from 
a chemically induced skin carcinogenesis model unraveled 
strong up-regulation of S100a8 and S100a9 (  24  ), both members 
of the S100 family of small molecular weight calcium-binding 
proteins (  11  ). The heterodimeric complex of S100a8/a9 is a 
well-known extracellular factor that engages with RAGE to in-
duce intracellular signaling (  11, 25, 26  ) and has recently emerged 
as an important proinfl  ammatory mediator in acute and chronic 
infl  ammation (  11, 27  –  29  ). In line with our previous fi  nd-
ings (  24  ), transcription of   S100a8   and   S100a9   was highly ele-
vated in TPA-treated   wt   skin, whereas transcript levels were 
largely reduced in   Rage      /        skin (  Fig. 3 A  ). Similar data were 
obtained in DMBA-initiated and TPA-treated skin, as shown 
    Figure 3.         Expression of proinfl  ammatory genes in TPA-treated mice.   (A) RQ-PCR was performed with cDNA from total   wt   and   Rage    /      skin  sam-
ples treated once with acetone (0 h) or with 10 nmol TPA in acetone and collected at the indicated time points and by using primers for   Mip-1    ,   Mip-1    , 
  Mip-2 ,   Ptgs2 ,   S100a8 ,   S100a9, Tnf-     , and   Tgf-    3   . Each cDNA from three mice of three separate animal experiments was analyzed in triplicates, and   Hprt  
transcripts served as an internal reference. Error bars represent the SEM. (B) Representative pictures of sections derived from tissue specimens as de-
scribed in A and analyzed for S100a9 and Mip-1      protein expression by IHC staining (brown signal) and followed by counterstaining with hematoxylin. 
Dashed lines indicate the border between the epidermis and dermis. co, acetone-treated controls. Bar, 20   μ  m.     280 RAGE SIGNALING PROMOTES INFLAMMATION AND CANCER | Gebhardt et al.
    Figure 4.         RAGE expression in immune cells is required for TPA-induced dermal infi  ltration and epidermal hyperplasia.   (A)   wt   and   Rage    /     
mice were treated with acetone (co) or 10 nmol of TPA three times every 48 h. Representative images are shown of hematoxylin-eosin – stained  skin  sec-
tions derived from specimens collected 3 d after the fi  nal treatment. Dashed lines indicate the border between the epidermis and dermis. Bar, 20   μ  m. 
(B) Representative images are shown of hematoxylin-eosin  –  stained skin sections derived from sublethally irradiated   wt   mice reconstituted with bone marrow JEM VOL. 205, February 18, 2008  281
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cells from   wt   or   Rage    /      mice  ( wt →  wt    or   Rage    /    →  wt   ), or sublethally irradiated   Rage    /      mice reconstituted with bone marrow cells from wt or   Rage    /     
mice (  wt →  Rage    /      or   Rage    /    →  Rage    /     ), and were treated as described in A (top two rows). Representative images of sections that were analyzed 
for S100a8 protein expression by IHC (brown staining; bottom two rows) and that were counterstained with hematoxylin. Dashed lines indicate the bor-
der between the epidermis and dermis. Bar, 20   μ  m. (C) Innate immune cells within the dermis of at least six chimeric mice of each group that were 
treated as described in B were counted based on specifi  c stainings as described in   Fig. 2 C  . (D) Percent totals of Ki67-positive keratinocytes of skin speci-
mens from at least three chimera of each group that were treated as described in B, measured, and analyzed as described in   Fig. 1 C  . Error bars represent 
the  SEM.   
 
hyperplasia (  Fig. 4 A  ; and Fig. S6 A, available at http://www
.jem.org/cgi/content/full/jem.20070679/DC1).   In contrast, 
  Rage      /        skin was almost resistant to repeated TPA treatment, 
with a signifi  cant impairment of epidermal hyperplasia (  Fig. 4 A  ), 
keratinocyte proliferation (P   <   0.003;   Fig. 5 A  ), dermal infi  ltra-
tion (mast cells, P   <   0.2; macrophages, P   <   0.0005; neutrophils, 
P   <   0.0005; Fig. S6 A), and up-regulation of S100a8 and S100a9 
proteins (  Fig. 5 B  ).   Moreover, the number of epidermal kera-
tinocytes with nuclear staining for phosphorylated p65/RelA 
protein was reduced on tissue sections of   Rage      /        skin compared 
with   wt   controls (Fig. S6 B). Collectively, these data suggest 
that RAGE is essential for TPA-induced tumor promotion, 
and we indeed found impaired epidermal hyperplasia in 
DMBA-initiated   Rage      /        animals upon repeated TPA appli-
cation after 1 wk as well as after 10 wk in the preneoplastic 
stage (Fig. S7). 
  It is noteworthy that S100 and MIP protein expression were 
detected in both epidermal keratinocytes and a variety of in-
fi  ltrating immune cells (Fig. S5; and Fig. S8, A and B, available 
at http://www.jem.org/cgi/content/full/jem.20070679/DC1), 
implying a critical contribution of multiple cell types in the 
TPA-induced up-regulation of proinfl  ammatory cytokines. 
Moreover, RAGE protein is expressed in a variety of distinct 
cell types (  11  ), including epidermal keratinocytes, tumor cells, 
endothelial cells, and a subset of innate immune cells such as 
neutrophils, macrophages, and mast cells (Fig. S8, C and D). 
To investigate whether RAGE expression on epithelial, en-
dothelial, or immune cells is required for TPA-induced der-
mal infi  ltration and epidermal hyperplasia, we analyzed mouse 
chimera after bone marrow transplantation. As expected,   wt   mice 
reconstituted with   wt   bone marrow cells (  wt  →  wt  ) and   Rage  -
defi  cient mice reconstituted with   Rage      /        bone marrow 
cells (  Rage      /       →  Rage      /       ) phenocopied the response of   wt   and 
  Rage  -defi  cient mice to repeated TPA treatment (  Fig. 4, B  –  D  ). 
  Rage  -defi  cient mice reconstituted with   wt   bone marrow cells 
(  wt  →  Rage      /       ) showed no signifi  cant diff  erence in epidermal 
hyperplasia, keratinocyte proliferation (P   >   0.1), and dermal 
infi  ltration by neutrophils (P   >   0.6), macrophages (P   >   0.1), and 
mast cells (P   >   0.5) compared with   wt  →  wt   chimera. How-
ever,   wt   mice reconstituted with   Rage      /        bone marrow cells 
(  Rage      /       →  wt  ) revealed impaired epidermal hyperplasia, kera-
tinocyte proliferation (P   <   0.0005), and dermal infi  ltration by 
neutrophils (P   <   0.005) and macrophages (P   <   0.005) com-
pared with   Rage      /       →  Rage      /        chimera. Collectively, we pro-
vide experimental evidence that RAGE expression on immune 
cells, but not keratinocytes or endothelial cells, is required for 
innate immune cell recruitment and induction of epidermal 
hyperplasia in vivo, which is in line with published data on a 
model of HMGB1-induced peritonitis (  30  ). However, IHC 
analysis on skin sections revealed reduced S100 protein levels 
for   wt  →  Rage      /        compared with   wt  →  wt   chimera (  Fig. 4 B  ), 
demonstrating that RAGE signaling is required for effi   cient 
S100a8 and S100a9 expression in keratinocytes. 
  Based on the bone marrow transfer experiment, the ques-
tion remained of whether an increase in the amount of infi  l-
trating cells by accelerated TPA application allows complete 
epidermal hyperplasia and tumor development in   Rage  -defi  cient 
mice. Indeed, more frequent TPA application (i.e., three 
times every 24 h) revealed dermal infi  ltration, keratinocyte 
proliferation, and epidermal hyperplasia in   Rage      /        skin that 
were almost comparable to   wt   skin (  Fig. 5, A and B  ; and 
Fig. S6, A and C). Again, expression of S100a8 and S100a9 pro-
teins was only partially restored in keratinocytes of   Rage      /        
skin and did not reach levels that were detected in epidermal 
keratinocytes of   wt   skin (  Fig. 5 B  ). Finally, we modifi  ed the 
DMBA/TPA protocol by applying TPA every 24 h during 
the promotion phase, resulting in a complete rescue regarding 
tumor incidence (P   >   0.2), with the fi  rst tumors appearing in 
  wt   and   Rage      /        mice within 5 wk of TPA-induced tumor 
promotion and with all animals in both groups developing tu-
mors within 6 wk (  Fig. 5 C  ). One explanation for this rescue 
using an accelerated TPA treatment could be the enhanced 
expression of other proinfl  ammatory cytokines and activation 
of bypassing signaling pathways. Indeed, we found high ex-
pression of Tnf-      protein in skin and tumor sections of both 
  wt   and   Rage      /        mice after TPA application every 24 h (  Fig. 5 B  ; 
and Fig. S9, available at http://www.jem.org/cgi/content/
full/jem.20070679/DC1). However, tumor multiplicity as well 
as tumor size were only partially restored, because the mean 
number of tumors per mouse in the group of   Rage      /        mice 
reached only 50% of the value determined for the   wt   group, 
and the tumors of   Rage      /        mice remained smaller in size com-
pared with   wt   tumors (  Fig. 5 C   and Fig. S1 B). 
  In summary, our data provide direct genetic evidence that 
RAGE mediates sustained skin infl  ammation upon exposure 
to the tumor promoter TPA and that RAGE is important for 
multistage skin carcinogenesis in mice. Given the close asso-
ciation between chronic infl  ammation and epithelial cancer, 
we propose that RAGE activation by its ligands, such as S100 
proteins, triggers a positive regulatory loop that maintains an 
infl  ammatory microenvironment required for the promotion 
of tumor development. Because other RAGE ligands, such as 
HMGB1 and AGEs, have been shown to be up-regulated in 
tumors (  8  ), we cannot exclude that these ligands serve as an 
additional source of RAGE activation within the established 
tumor. Although, we found that RAGE expression on immune 282 RAGE SIGNALING PROMOTES INFLAMMATION AND CANCER | Gebhardt et al.
    Figure 5.         Epidermal hyperplasia and tumor promotion after accelerated TPA treatment.   (A)   wt   and   Rage    /      mice were treated with acetone (co) 
or 10 nmol TPA three times every 48 or 24 h, respectively, on the shaved back skin. Shown are the percent totals of Ki67-positive keratinocytes of three 
skin specimens from each genotype that were measured and analyzed as described in   Fig. 1 C  . (B) Representative images of skin sections from mice 
treated as described in A that were analyzed for S100a8, S100a9, and Tnf-      protein expression by IHC (brown staining) and counterstained with hema-
toxylin. Bar, 20   μ  m. (C)   wt   and   Rage    /      mice were subjected to a modifi  ed DMBA/TPA skin carcinogenesis protocol with TPA treatment every 24 h and 
were analyzed as described in Materials and methods.     JEM VOL. 205, February 18, 2008  283
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cells was suffi   cient for TPA-induced dermal infi  ltration as well 
as epidermal hyperplasia, and that accelerated TPA treatment 
resulted in effi   cient tumor development in   Rage      /        animals, 
we still observed reduced S100a8 and S100a9 protein expres-
sion in keratinocytes lacking RAGE expression and only a 
partial rescue in tumor multiplicity. Thus, RAGE expres  sion 
on keratinocytes might also contribute to the transformation 
and malignant progression of epithelial cells, and it will be 
a challenge for the future to investigate cell type  –  specifi  c 
RAGE knockout mice using the DMBA/TPA model. Overall, 
S100/RAGE signaling appears to be an appropriate target for 
the development of novel therapies aff  ecting both chronic 
infl  ammatory disorders and epithelial malignancies. 
  MATERIALS AND METHODS 
  Animals.       Rage      /        animals were described previously (  31, 10  ), and   wt   con-
trols were obtained from Charles River Laboratories. Both   wt   and   Rage      /        
mice were on a C57BL/6 background (  10  ) and were housed in an insulator 
under specifi  c pathogen-free and negative-pressure conditions. 
  Animal work and sample preparation.     All animal experiments were 
performed with 7  –  9-wk-old female   wt   and   Rage      /        mice. Skin tumors were 
generated according to the initiation-promotion protocol of DMBA/TPA-
induced multistage carcinogenesis (  6  ), with a single dose of DMBA (100 nmol/
100   μ  l acetone; Sigma-Aldrich) followed by repetitive TPA applications 
(10 nmol/100   μ  l acetone) every 48 h (  n   = 21 mice per genotype) or in an 
accelerated manner every 24 h (  n   = 10 mice per genotype). Acetone-
treated controls (acetone/acetone, DMBA/acetone, or acetone/TPA) served 
as internal controls and did not develop any tumors. Tumors were assessed 
weekly per individuum and were defi  ned as raised lesions of a minimum di-
ameter of 1 mm that had been present for at least two consecutive weeks. 
Mice were killed 6 wk after the fi  nal treatment (representing week 36 after 
initiation for the classical protocol and week 13 after initiation for the accel-
erated protocol). For single and repetitive TPA application,   wt   and   Rage      /        
animals were shaved on the dorsal skin and treated 3 d later topically with 
100   μ  l acetone as a control or TPA (10 nmol/100   μ  l acetone;   n   = 6 mice per 
genotype and treatment). Chronic responses were achieved by 3  ×   topical 
treatment every 48 h or every 24 h, respectively (  n   = 6 mice per genotype 
and treatment). Animals were killed at the times indicated in the fi  gures or 3 d 
after the fi  nal application. Initiation was achieved with a single treatment 
with DMBA (100 nmol/100   μ  l acetone) or with 100   μ  l acetone as a control 1 wk 
before topical TPA treatment (  n   = 4 mice per genotype and treatment). 
Tumors and skin necropsies were immediately frozen in liquid nitrogen after 
isolation for RNA preparation. For histological analysis, tissues were fi  xed 
with 4% paraformaldehyde (PFA) in PBS, pH 7.4, paraffi   n embedded, or 
embedded in optimum cutting temperature cryomedium (Sakura) and, sub-
sequently, cut into 6-  μ  m sections as described previously (  24, 32  ). Tissue sections 
were stained with hematoxylin-eosin and were examined by several experienced 
experimenters. The procedures for performing animal experiments were in 
accordance with the principles and guidelines of the Arbeitsgemeinschaft 
der Tierschutzbeauftragten in Baden-W  ü  rttemberg and were approved by the 
Regierungspr  ä  sidium of Karlsruhe, Germany (AZ 129/02). 
  Generation of bone marrow chimeras.     Bone marrow chimeras were 
prepared as described previously (  33  ). Reconstitution was confi  rmed by 
FACS analysis using specifi  c markers for leukocyte populations (unpublished 
data). TPA treatment was performed 10 wk after the bone marrow transfer. 
  Tumor grading.     Hematoxylin-eosin  –  stained tissue sections of   wt   and   Rage      /        
tumors were graded in a blinded manner by two experts in mouse skin pathology. 
Grades followed a recent publication (  34  ) and were assigned as follows: papilloma 
grade 1, papilloma grade 2, papilloma with focal microinvasion, or squamous 
cell carcinoma. 
  BrdU incorporation assay.     BrdU in vivo incorporation was performed 
according to the manufacturer  ’  s recommendations (Roche). Mice were in-
jected into the tail vein with 100   μ  g/g BrdU dissolved in PBS 90 min before 
sacrifi  ce. The skin was fi  xed with 4% PFA in PBS, pH 7.4, and paraffi   n 
embedded. Tissue sections were analyzed by IF stainings. 
  Histochemical and immunostaining analyses.     IHC analysis on paraffi   n 
sections was performed according to the manufacturer  ’  s instructions (Vector 
Laboratories), and sections were counterstained with hematoxylin. IF analy-
sis was performed as described previously (  19, 32, 35  ), and nuclear staining 
was done with H33342 (EMD). A summary of all primary antibodies that 
were used is provided in Table S1 (available at http://www.jem.org/cgi/
content/full/jem.20070679/DC1). For BrdU detection, IF analysis was per-
formed using the M.O.M. immunodetection kit (Vector Laboratories). Mast 
cells on tissue sections were detected by toluidine blue staining. TUNEL as-
say was performed using the In Situ Cell Death Detection Kit, according to 
the manufacturer  ’  s recommendations (Roche). 
  Image analysis.     Tissue sections derived from at least three independent 
samples per genotype were analyzed by experimenters without the knowl-
edge of the coded sample identity. Stained sections were visualized by bright 
fi  eld or IF microscopy (DMLB; Leica) using a digital camera (DXM1200; 
Nikon) and software (ACT-1; Nikon). Confocal microscopy was done us-
ing a confocal microscope (TCS SP5; Leica) and software (LAS AF; Leica). 
Image processing was performed with Photoshop CS software (Adobe). 
  RQ-PCR.     Total RNA was isolated from mouse back skin necropsies using 
peqGOLD RNAPure (peqlab Biotechnologie) according to the manufac-
turer  ’  s protocol. RNA integrity was confi  rmed by agarose gel electrophore-
sis (Agilent Bioanalyzer 2100; Agilent Technologies). RNA was reverse 
transcribed using RevertAid H Minus-MuLV RT (Fermentas) and oligo-dT 
primers, followed by standard RQ-PCR performed on a detection system 
(MyiQ; Bio-Rad Laboratories) using the Absolute QPCR SYBR green 
fl  uorescein mix (Abgene). Primer sequences are listed in Table S2 (available at 
http://www.jem.org/cgi/content/full/jem.20070679/DC1). Target gene 
computed tomography (CT) values were normalized to the corresponding 
CT values of   Hprt   using the      CT method. Expression levels for acetone-treated 
  wt   controls were set to one to calculate relative transcript levels. Each cDNA 
was analyzed in triplicates, and the error bars represent the SEM. 
  Statistical analysis.     For the statistical analysis of the DMBA/TPA experi-
ments, the exact   W  ilcoxon rank sum test was used for comparison of the 
individual maximum number of papilloma of each animal, and the log-rank test 
was used for the comparison of the time to fi  rst papilloma (  6  ). The prolifera-
tion index was calculated from the percentage of total of BrdU- or Ki67-
positive epithelial cells, which were counted on stained skin or tumor sections 
from at least three diff  erent samples of each genotype. Quantifi  cation of in-
nate immune cells was performed with stained skin or tumor sections of 
  wt   and   Rage      /        mice. Stained cells were counted on tissue sections from three 
diff  erent papillomas of each genotype or from three diff  erent mice of each 
genotype per treatment and/or time point. As multiple measurements were 
obtained from every tumor or skin sample, mixed linear models were used to 
test whether the variables of interest diff  er between the genotypes. The analy-
ses were performed using PROC MIXED (version 9.1; SAS Institute, Inc.) 
with compound symmetry covariance structure. QQ plots were used to assess 
whether the variables of interest follow a normal distribution. However, non-
parametric alternatives are not available for the analysis of repeated measures. 
The columns represent means and the error bars represent the SEM for the 
mean values. P   ≤   0.05 was considered signifi  cant. In all cases, the group size 
was chosen to produce results that are statistically unambiguous. 
  Online supplemental material.     Table S1 lists all antibodies used for IHC 
and IF analysis, and Table S2 lists all sequences of primers used for RQ-
PCR. Fig. S1 provides tumor sizes and grading of the chemically induced 
skin tumors derived from   wt   and   Rage      /        mice. Fig. S2 shows quantifi  cations of 284 RAGE SIGNALING PROMOTES INFLAMMATION AND CANCER | Gebhardt et al.
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